These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34539813)

  • 1. Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
    Bor S; Lehert P; Chalbaud A; Tack J
    Therap Adv Gastroenterol; 2021; 14():17562848211033740. PubMed ID: 34539813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
    Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysis.
    Shi YZ; Tao QF; Qin D; Chen M; Yu SG; Zheng H
    Front Physiol; 2022; 13():1001978. PubMed ID: 36277191
    [No Abstract]   [Full Text] [Related]  

  • 4. Acupuncture for treatment of irritable bowel syndrome.
    Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD005111. PubMed ID: 22592702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial.
    Zheng L; Lai Y; Lu W; Li B; Fan H; Yan Z; Gong C; Wan X; Wu J; Huang D; Wang Y; Mei Y; Li Z; Jiang Z; Liu X; Ye J; Yang Y; Huang H; Xiao J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1285-1292.e1. PubMed ID: 25632806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis.
    Qin D; Tao QF; Huang SL; Chen M; Zheng H
    Front Pharmacol; 2022; 13():757969. PubMed ID: 35281934
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis.
    Martínez-Vázquez MA; Vázquez-Elizondo G; González-González JA; Gutiérrez-Udave R; Maldonado-Garza HJ; Bosques-Padilla FJ
    Rev Gastroenterol Mex; 2012; 77(2):82-90. PubMed ID: 22672854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acupuncture and pinaverium bromide in the treatment of irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Li H; Chen Y; Hu Z; Yi Y; Ye J; Zhou Y; Yu Z; Tang H
    Medicine (Baltimore); 2021 Apr; 100(16):e25604. PubMed ID: 33879727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial.
    Schmulson MJ; Chiu-Ugalde J; Sáez-Ríos A; López-Colombo A; Mateos-Pérez GJ; Remes-Troche JM; Sobrino-Cossio S; Soto-Pérez JC; Tamayo de la Cuesta JL; Teramoto-Matsubara OT; López-Alvarenga JC
    J Clin Gastroenterol; 2020 Apr; 54(4):e30-e39. PubMed ID: 31385885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.
    Zheng L; Lu W; Xiao Q; Lai Y; Fan H; Sun Y; Huang D; Wang Y; Li Z; Jiang Z; Liu X; Zhang L; Zuo D; Shou Z; Tang Q; Huang H; Yang Y; Tang Z; Xiao J
    Sci Rep; 2021 Jul; 11(1):13894. PubMed ID: 34230526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probiotics and dietary fiber combined with pinaverium bromide on intestinal flora in patients with irritable bowel syndrome.
    Sun H; Li X; Chen W; Jia F; Su J; Zhang B; Wu X; Wu P
    Am J Transl Res; 2021; 13(12):14039-14045. PubMed ID: 35035746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta-analysis.
    Chen M; Qin D; Huang SL; Tang TC; Zheng H
    Neurogastroenterol Motil; 2021 Aug; 33(8):e14107. PubMed ID: 33660903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of cognitive behavioral therapy combined with pinaverium bromide tablets on irritable bowel syndrome.
    Liu Q; Zhu Y; Wang W; Dong Y
    Pak J Med Sci; 2023; 39(4):1013-1017. PubMed ID: 37492283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity for treatment of irritable bowel syndrome.
    Nunan D; Cai T; Gardener AD; Ordóñez-Mena JM; Roberts NW; Thomas ET; Mahtani KR
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD011497. PubMed ID: 35766861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongxie Formula Reduces Symptoms of Irritable Bowel Syndrome.
    Fan H; Zheng L; Lai Y; Lu W; Yan Z; Xiao Q; Li B; Tang M; Huang D; Wang Y; Li Z; Mei Y; Jiang Z; Liu X; Tang Q; Zuo D; Ye J; Yang Y; Huang H; Tang Z; Xiao J;
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1724-1732. PubMed ID: 28634136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.
    Menees SB; Maneerattannaporn M; Kim HM; Chey WD
    Am J Gastroenterol; 2012 Jan; 107(1):28-35; quiz 36. PubMed ID: 22045120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.